Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP015K plus DMARDs in rheumatoid arthritis (phase 3)
CTR20181199Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Jul 2018; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20181199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181199.